Pulmonary Drug Delivery Market Global Industry Size, Share, Demand, Growth Analysis and Forecast By 2030
The scope of this Global Pulmonary Drug Delivery Market report extends from market scenarios to comparative pricing between major players, cost and profit of the specified market regions. To turn complex market insights into simpler version, well established tools and techniques are used in this report. The most relevant, unique, fair and creditable global market research report is delivered to the valuable customers and clients depending upon their specific business needs. The quality and transparency maintained in the Global Pulmonary Drug Delivery Market research report makes gain the trust and reliance of member companies and customers.
Data Bridge Market Research analyses that the pulmonary drug delivery market, valued at USD 47.85 billion in 2022, will reach USD 72.88 billion by 2030, growing at a CAGR of 5.4% during the forecast period of 2023 to 2030.
Download Sample PDF Copy of this Report to understand structure of the complete report (Including Full TOC, Table & Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-pulmonary-drug-delivery-market
Market Overview
Directing the drug to the intended site is referred to as "targeted drug delivery." A targeted drug delivery system called pulmonary drug delivery requires the drug moiety toward the lower respiratory tract. A device used to administer medications to the body via the pulmonary route is called a pulmonary drug delivery system. The inhalation route offers a superior alternative to oral administration for treating asthma and chronic obstructive pulmonary disease. Instantaneous action from pulmonary drug delivery relieves acute bronchitis and asthmatic attacks. For pulmonary drug delivery, aerosols are specially made-devices.
Some of the major players operating in the pulmonary drug delivery market are:
-
F. Hoffmann-La Roche Ltd (Switzerland)
-
MannKind Corporation (U.S.)
-
OMRON Healthcare, Inc. (Japan)
-
Mylan N.V (U.S.)
-
3M (U.S.)
-
Koninklijke Philips N.V. (Netherlands)
-
Merck & Co., Inc., (U.S.)
-
Teva Pharmaceutical Industries Ltd. (Israel)
-
Sunovion Pharmaceuticals Inc. (U.S.)
-
PARI GmbH (Germany)
-
Jabil Inc. (U.S.)
-
AstraZeneca (U.K.)
-
Boehringer Ingelheim International GmbH. (Germany)
-
GSK plc. (U.K.)
-
Novartis AG (Switzerland)
-
Aerogen Pharma (Ireland)
-
Briggs Healthcare (U.S.)
-
HAAG-STREIT GROUP (Switzerland)
-
Janssen Global Services, LLC (U.S.)
-
AptarGroup, Inc. (U.S.)
Pulmonary Drug Delivery Market Regional Analysis/Insights
-
The pulmonary drug delivery market is analysed and market size insights and trends are provided by country, formulations, canister type, application, and end-user as referenced above.
-
The countries covered in the pulmonary drug delivery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
-
North America dominates the market due to the growing prevalence of respiratory and lung disorders, technological advancement, and increasing awareness. Furthermore, through an increase in the prevalence of pulmonary diseases, the presence of major players in the production and development of drugs for pulmonary diseases, an increase in the number of hospitals and diagnostic facilities, and government initiatives for treating pulmonary diseases in the area.
-
Asia-Pacific is expected to show a rapid and lucrative growth rate in the forecast period owing to Japan's increasing disposable and rising geriatric population. Moreover, the rising patient count with respiratory and acceptance of pulmonary drug devices will boost the region market, whereas increasing government initiatives to improve healthcare infrastructure will also expand market growth.
-
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Browse More About This Research Report @ https://www.databridgemarketresearch.com/reports/global-pulmonary-drug-delivery-market Highlights of TOC
Chapter 1: Market overview
Chapter 2: Global Pulmonary Drug Delivery Market
Chapter 3: Regional analysis of the Global Pulmonary Drug Delivery industry
Chapter 4: Global Pulmonary Drug Delivery segmentation based on types and applications
Chapter 5: Revenue analysis based on types and applications
Chapter 6: Market share
Chapter 7: Competitive Landscape
Chapter 8: Drivers, Restraints, Challenges, and Opportunities
Chapter 9: Gross Margin and Price Analysis
Get the Full Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-pulmonary-drug-delivery-market
Browse Trending Reports:
About Data Bridge Market Research:
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
Contact Us: -
Data Bridge Market Research
US: +1 888 387 2818
United Kingdom: +44 208 089 1725
Hong Kong: +852 8192 7475
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian